Squarepoint’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,856
Closed -$21.5K 4436
2024
Q1
$21.5K Sell
14,856
-294
-2% -$417 ﹤0.01% 3926
2023
Q4
$22.7K Buy
15,150
+195
+1% +$352 ﹤0.01% 3907
2023
Q3
$31.3K Buy
14,955
+143
+1% +$333 ﹤0.01% 3675
2023
Q2
$34.1K Sell
14,812
-1,845
-11% -$4.07K ﹤0.01% 3467
2023
Q1
$36K Sell
16,657
-2,087
-11% -$4.78K ﹤0.01% 3082
2022
Q4
$38.4K Buy
+18,744
New +$41.4K ﹤0.01% 3078
2021
Q3
Sell
-28,504
Closed -$121K 3226
2021
Q2
$121K Buy
+28,504
New +$123K ﹤0.01% 2982
2020
Q3
Sell
-10,473
Closed -$57K 2708
2020
Q2
$57K Buy
+10,473
New +$55.5K ﹤0.01% 2086
2020
Q1
Sell
-41,396
Closed -$279K 2270
2019
Q4
$279K Buy
41,396
+10,961
+36% +$82.4K ﹤0.01% 2074
2019
Q3
$242K Buy
30,435
+9,233
+44% +$82.3K ﹤0.01% 2002
2019
Q2
$204K Buy
21,202
+7,234
+52% +$76.3K ﹤0.01% 2098
2019
Q1
$116K Buy
+13,968
New +$122K ﹤0.01% 2021
2018
Q4
Sell
-14,000
Closed -$175K 2131
2018
Q3
$175K Buy
+14,000
New +$141K ﹤0.01% 1804

Other funds holding MNOV

Squarepoint's MNOV Position: Q2 2024 in Review

Squarepoint sold out of MediciNova (MNOV) in Q2 2024, closing a stake of 14,856 shares — an estimated $21.5K sold.

Squarepoint first reported a position in MNOV in Q3 2018 and held it in 13 quarters. The position peaked at $279K in Q4 2019. 33 funds tracked by Wall St. Rank hold MNOV as of Q2 2024.

  • Squarepoint reported no remaining MediciNova position as of Q2 2024 after selling out during the quarter.
  • Squarepoint sold 14,856 MediciNova shares in Q2 2024, an estimated $21.5K.
  • Squarepoint first reported a position in MediciNova in Q3 2018 and held it in 13 quarters.
  • Squarepoint's MediciNova position peaked at $279K in Q4 2019.
  • 33 funds tracked by Wall St. Rank held MediciNova as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.